Zydus Lifesciences Receives 'Leader' Category ESG Rating of 71 from NSRAL
Zydus Lifesciences Ltd 路 Others (Uncategorized) 路 16 Oct 2026, 10:24 pm
Zydus Lifesciences Receives 'Leader' Category ESG Rating of 71 from NSRAL NSE Sustainability Ratings and Analytics Limited (NSRAL) has assigned an overall ESG rating of 71 to Zydus Lifesciences Limited for FY26, categorizing the pharmaceutical company as a 'Leader'. Received on 15th Oct'26, the unsolicited rating was prepared independently by the SEBI-registered ESG rating provider utilizing publicly available data.
Original exchange filing (PDF)
More announcements from Zydus Lifesciences Ltd
- Press Release 路 14 Nov 2026
- Completion of transaction 路 12 Nov 2026
- Transcript of the post results earnings call held on November 4, 2026. 路 07 Nov 2026
- Press Release 路 07 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Life Insurance Corporation of India 路 06 Nov 2026
- Investor Conference 路 06 Nov 2026
- Audio recording of the Company's Investor Call 路 05 Nov 2026
- Press Release 路 04 Nov 2026
